WHO Expands Global Contraception Guidelines
Analysis based on 6 articles · First reported Sep 23, 2026 · Last updated Sep 24, 2026
The guidance expands the addressable market for contraceptive products, particularly long-acting implants, emergency contraceptives such as mifepristone, and future male contraceptives, benefiting pharmaceutical and medical device makers with approved products. It also signals a multi-year research and development pipeline opportunity, though near-term revenue effects are limited and the recommendation against quinestrol and caution on ormeloxifene could weigh on makers of those specific products.
The World Health Organization published new guidelines on expanding contraceptive options, recommending a wider range of safe and effective methods and new ways to use existing ones. The guidance allows combined oral contraceptive pills to be taken for extended periods of up to six months or continuously for up to one year, and supports use of contraceptive implants for up to five years, which could reduce replacement procedures, clinic visits and costs. WHO also recommended mifepristone at doses of 10 to 50 mg as an additional emergency contraception option, taken as soon as possible and within five days of unprotected sex. The organization called for more research on ormeloxifene due to limited safety evidence and recommended against adding quinestrol-containing pills to national family planning programmes. WHO additionally published its first Target Product Profile for male contraceptive methods, setting out safety, effectiveness, acceptability and affordability criteria, and noted that several hormonal and non-hormonal male candidates are in advanced clinical trials, with new reversible male contraceptives potentially reaching the market within five to 10 years. The guidelines respond to an estimated 164 million women who want to delay or avoid pregnancy but are not using contraception.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard